Wednesday, December 5, 2012

• Stem Cell Research Gets Boost From New Cell Bankat Investor's Business Daily (Wed, Dec 5)
• Why Job Growth Is Overratedat Forbes (Wed, Dec 5)

Tuesday, December 4, 2012

• Big Pharma Sees More Approvals, Disappointing Revenues: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Dec 4)
• Court finds U.S. cannot prosecute off-label sales of drugs, Bloomberg reportstheflyonthewall.com (Tue, Dec 4)

Thursday, November 29, 2012

• NVS Discusses Data Readout PlansZacks (Thu, Nov 29)

Wednesday, November 28, 2012

• Pfizer Completes NextWave Purchase, Nymox Completes Patient Enrollment: Healthcare Business Recapat Wall St. Cheat Sheet (Wed, Nov 28)
• Elan Starts Phase II AD StudyZacks (Wed, Nov 28)

Monday, November 26, 2012

• Illumina Stock Falls As Analyst Warns Of Competitionat Investor's Business Daily (Mon, Nov 26)
• What Are Best Global Stocks Now? This Proven Genius Has Answersat Forbes (Mon, Nov 26)
• Illumina downgraded to Neutral from Outperform at RW Bairdtheflyonthewall.com (Mon, Nov 26)
• [video] A Bubble In The BRICs?at Forbes (Mon, Nov 26)

Wednesday, November 21, 2012

• VIVUS rallies after Aetna revises obesity drug policyat theflyonthewall.com (Wed, Nov 21)

Tuesday, November 20, 2012

• Glaxo's Promacta Label ExpandedZacks (Tue, Nov 20)

Monday, November 19, 2012

• Game Changer in Hospital Labs?at Motley Fool (Mon, Nov 19)
• Alnylam-Tekmira Settle UpZacks (Mon, Nov 19)

Saturday, November 17, 2012

• Genentech Study Showed That Avastin Helped People with Newly Diagnosed Glioblastoma Live Longer without Their Disease Worsening When Added to Radiation and ChemotherapyBusiness Wire (Sat, Nov 17)

Friday, November 16, 2012

• Abraxane Cancer Trials Help Justify Celgene Buyoutat Investor's Business Daily (Fri, Nov 16)

Thursday, November 15, 2012

• Still Neutral on DexComZacks (Thu, Nov 15)
• Dynavax’s Potential 1st Product, Roche Sells Cancer Insurance: Healthcare Business Recapat Wall St. Cheat Sheet (Thu, Nov 15)

Tuesday, November 13, 2012

• Agilent, Roche Sign AgreementZacks (Tue, Nov 13)

Monday, November 12, 2012

• Roche announces U.S. market availability of Elecsys HE4 assaytheflyonthewall.com (Mon, Nov 12)

Saturday, November 10, 2012

• ADACTA Study Showed ACTEMRA Improved Signs and Symptoms of Rheumatoid Arthritis Significantly More Than Adalimumab as a Single-Agent TherapyBusiness Wire (Sat, Nov 10)

Friday, November 9, 2012

• Jazz Pharma 3Q Earnings In LineZacks (Fri, Nov 9)

Wednesday, November 7, 2012

• Agilent Technologies and Roche Establish Agreement to Provide Continued Service and Support to Roche NimbleGen Microarray CustomersBusiness Wire (Wed, Nov 7)
• PDLI's EPS In Line, Revenue MissesZacks (Wed, Nov 7)

Add RHHBY News to My Yahoo!